Tenosynovial giant cell tumor
ORPHA:66627DiseaseNot applicableAdolescent, Adult, Childhood
Фенотипы (HPO)24
Очень частый (80–99%)1
HP:0002829Arthralgia
Частый (30–79%)7
HP:0001369Arthritis
HP:0001376Limitation of joint mobility
HP:0001386Joint swelling
HP:0001387Joint stiffness
HP:0002797Osteolysis
HP:0002815Abnormality of the knee
HP:0005261Joint hemorrhage
Периодический (5–29%)12
HP:0000372Abnormality of the auditory canal
HP:0000405Conductive hearing impairment
HP:0001003Multiple lentigines
HP:0001004Lymphedema
HP:0001384Abnormality of the hip joint
HP:0003019Abnormality of the wrist
HP:0003028Abnormality of the ankles
HP:0003043Abnormality of the shoulder
HP:0009811Abnormality of the elbow
HP:0009911Abnormal temporal bone morphology
HP:0031520Groin pain
HP:0040090Abnormality of the tympanic membrane
Очень редкий (1–4%)4
HP:0000934Chondrocalcinosis
HP:0005186Synovial hypertrophy
HP:0005195Polyarticular arthropathy
HP:0040161Localized osteoporosis
Эпидемиология1
| Тип оценки | Класс распространённости | Среднее (на 100к) | Регион | Квалификация |
|---|---|---|---|---|
| Point prevalence | 1-5 / 10 000 | 20 | Europe | Value and class |
Лекарства и терапия
Источник: Open Targets Platform (в реальном времени)
Клинические исследования
Источник: ClinicalTrials.gov (в реальном времени)